Notes / Company

Tatva Chintan Pharma Chem Ltd.

TATVA BSE 543321 ISIN INE0GK401011 Chemicals

Fundamentals

Market cap: ₹2,762 cr
P/E: 65.68×
ROE: 0.77%
Debt / equity: 0.05
Div yield: 0.16%
52-week range: 919.75 — 1610.00

The timeline — 1 note on Tatva Chintan Pharma Chem Ltd.

July 2026

17 Jul 26 · 3:49 PM IST Lead

Lead · Small cap

Tatva Chintan bets ₹200 cr on Dahej-III, borrowing limit to ₹1,000 cr

Q1 revenue up 43%, net profit more than doubled. But the real news is the greenfield expansion: a 344 KL capacity bet worth 40% of annual revenue, funded by a first move into debt.

Verify on exchange BSE filings for TATVA NSE filings for TATVA